Company / Interest Expense
BioRestorative Therapies, Inc. Interest Expense History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$552.3K
FY2024
5-year range
$552.3K / $552.3K
FY2020-FY2024
Trend
-
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $9,679 to $552,293 over the past 8 years.
Based on SEC 10-K filings.
$552,293 in FY2024.
Increased from $9,679 to $552,293 over the past 8 years.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -47.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $552.3K | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | $208.0K | +2048.9% |
| FY2016 | $9.7K | -96.6% |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026